Tolerance and pharmacokinetics of PEG-INF-SA in healthly volunteers: Randomized, Single center, Dose-ranging, Open-Label study.
Phase of Trial: Phase I
Latest Information Update: 15 Jul 2013
At a glance
- Drugs Peginterferon SA (Primary)
- Indications Hepatitis
- Focus Adverse reactions; Pharmacokinetics
- 15 Nov 2011 Actual initiation date changed from Nov 2010 to Oct 2010 as reported by Chinese Clinical Trial Register record.
- 30 Jun 2011 New trial record